CN104513807B - The method for cloning non-human animal is separated, cultivates the method for cell and carried out from blood - Google Patents

The method for cloning non-human animal is separated, cultivates the method for cell and carried out from blood Download PDF

Info

Publication number
CN104513807B
CN104513807B CN201310461790.9A CN201310461790A CN104513807B CN 104513807 B CN104513807 B CN 104513807B CN 201310461790 A CN201310461790 A CN 201310461790A CN 104513807 B CN104513807 B CN 104513807B
Authority
CN
China
Prior art keywords
cell
culture
blood
mononuclearcell
culture medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310461790.9A
Other languages
Chinese (zh)
Other versions
CN104513807A (en
Inventor
杨珍珍
徐颖
林木飞
杜玉涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Huada Gene Agriculture Holding Co ltd
Original Assignee
BGI ARK BIOTECHNOLOGY Co Ltd SHENZHEN
BGI Shenzhen Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BGI ARK BIOTECHNOLOGY Co Ltd SHENZHEN, BGI Shenzhen Co Ltd filed Critical BGI ARK BIOTECHNOLOGY Co Ltd SHENZHEN
Priority to CN201310461790.9A priority Critical patent/CN104513807B/en
Publication of CN104513807A publication Critical patent/CN104513807A/en
Application granted granted Critical
Publication of CN104513807B publication Critical patent/CN104513807B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention provides a kind of separation from blood, the method for cultivating cell and a kind of method cloned to non-human animal.The method for being separated from blood, cultivating cell comprises the following steps:The blood is added to behind separating liquid upper strata and centrifuged using the mode of density gradient centrifugation, to obtain mononuclearcell;The mononuclearcell is inoculated in the in vitro culture equipment containing attached cell culture medium, to obtain attached cell;And the attached cell is subjected to Secondary Culture, to obtain the donorcells of body-cell neucleus transplanting.The donorcells for the body-cell neucleus transplanting that this method obtains is used directly for handmade cloning non-human animal, not only operating process is simple, be easily achieved, cost is relatively low, and this method is stimulated less Animal stress, injury is small, it is ensured that the integral outer appearance of animal, improves animal welfare.

Description

The method for cloning non-human animal is separated, cultivates the method for cell and carried out from blood
Technical field
The present invention relates to biology field, in particular it relates to which method and the clone of cell are separated, cultivated from blood The method of non-human animal.
Background technology
Body-cell neucleus transplanting is also known as cloned, and is the most frequently used technological means of System in Animal Cell Biotechnology.By electric shocking method or directly The higher body cell of differentiation degree is transferred in egg mother cell by microinjection, then by chemokinesis, reprograms it Embryo is developed into, is transplanted back in foster mothers, complete individuals of being born.Traditional somatic cell nuclear transfer technique need it is expensive, Accurate micromanipulation system, it is very high to the technical requirements of operating personnel, it is not suitable for large-scale cloned animal production.
2001, Danish scientist Gabor Vajta proposed handmade cloning technology first, the maximum key point of the technology It is to utilize blade to realize " cutting stoning ", so as to be completely free of micromanipulation system, reduces the instrument throwing for cloning this technology Enter and artificial expenditure cost, make it possible that this technology of clone is applied to following industrialization.Body-cell neucleus transplanting at present Blastocyst rate between 20%-30%, and handmade cloning animal blastocyst rate can be improved to 40%-60%.
Thus, the donor cell source currently used for somatic cell cloning still has much room for improvement.
The content of the invention
It is contemplated that at least solves one of above-mentioned technical problem to a certain extent.
The present invention is inventor based on the fact that finding:In recent years, cloned animal increasingly have its it is wide should With prospect, such as the cultivation available for high-quality poultry kind, to be advantageous to animals on the brink of extinction Germ-plasma resources protection;All kinds of experiments are produced to move Thing, being derived from experimental animal has the characteristics that inhereditary material homogeneity, phenotype uniformity, is more suitable for pharmacology items and grinds Study carefully;Clone is applied into transgenosis, can high efficiency obtain transgenic animals, shorten experimental period, largely obtain transgenic animals. During body-cell neucleus transplanting, donorcells species is various, including is filled between the embryonic stem cell with multipotency, fat Matter stem cell, and terminal differentiation cell fibroblast, liver cell, granular cell, liver cell etc..Derived from embryonic stem cells In the inner cell mass of blastula stage, generations up to a hundred can be exceeded by being cultivated on feeder cells, but cumbersome, be unsuitable for building on a large scale System's passage, and due to the particularity in its source, the relevant information of adult animal can not be obtained, clone has for high-quality germline Certain limitation;And the mescenchymal stem cell attached cell in bone source, mainly by the marrow in separating animal's femur and Target cell is obtained, but the sample for using the method to collect is acquired, it is necessary to which animal is first put to death to facilitate;Other sources For donor cell, tissue, organ wounds can be all caused to animal individual to varying degrees.It is at present the most normal into fiber Clone's cell somatic types, but for the big animal such as pig, ox, sheep, it is substantially and gathers its ear-edge tissue and carry out in vitro Original cuiture, but the reason such as growing environment factor due to itself, sample collection it is difficult to ensure that sterile, train in vitro by the later stage It is very high to support bacterium, the probability of fungal contamination in preparation process.
Therefore, it is an object of the present invention to propose that a kind of stress stimulation to animal is few, injury is small, ensure outside animal See the method for completely being separated from blood, cultivating cell.This method comprises the following steps:The blood is added to separating liquid Centrifuged behind upper strata using the mode of density gradient centrifugation, to obtain mononuclearcell;The mononuclearcell is inoculated with In the in vitro culture equipment containing attached cell culture medium, to obtain attached cell;And the attached cell is passed It is commissioned to train foster, to obtain the donorcells of body-cell neucleus transplanting.By the extraction according to embodiments of the present invention from blood, cultivate The donorcells of body-cell neucleus transplanting prepared by the method for cell is used for handmade cloning body-cell neucleus transplanting, and blastaea efficiency is in highest Up to 55%, average blastocyst rate is 40% or so.Thus, the side for being separated from blood, cultivating cell according to embodiments of the present invention Not only operating process is simple for method, be easily achieved, cost is relatively low, and this method is stimulated less Animal stress, injury is small, it is ensured that The integral outer appearance of animal, improve animal welfare.
In addition, the method for being separated from blood, cultivating cell according to embodiments of the present invention can also be with following additional Technical characteristic:
According to an embodiment of the invention, the blood comes from peripheral blood.Due to peripheral blood acquisition operations are relatively easy, to dynamic Thing stress stimulation is few, injury is small, thus can not only improve animal welfare, and blood is comparatively closed with the external world, and the later stage is thin Born of the same parents' culture pollution rate is substantially zeroed, improves cell survival rate.
According to an embodiment of the invention, the separating liquid is neutrophil leucocyte separating liquid.Thus, it is possible to effectively pass through profit The various cell components in blood are separated according to the size of density with the mode of density gradient centrifugation, by centrifugally operated If blood is divided into dried layer, contain different blood cell components in every layer, so as to effectively obtain mononuclearcell.
According to an embodiment of the invention, the density of the neutrophil leucocyte separating liquid is 1.077g/mL, wherein, in described Property granulocyte separating liquid contains 57g/L ficolls and 90g/L Sodium Amidotrizoates.Thus, the neutrophil leucocyte containing mentioned component point Chaotropic improves the separative efficiency of different cell components in separation blood, so as to which effectively mononuclear cell layer obtains therefrom Mononuclearcell in blood.
According to an embodiment of the invention, the mononuclearcell is collected from intermediate layer after separating liquid centrifugation.Profit Blood added in above-mentioned separating liquid with the mode of density gradient centrifugation after being centrifuged, blood quilt in above-mentioned separating liquid If being divided into dried layer, contain different cell components in every layer respectively, thus, it is possible to directly collect mononuclearcell from intermediate layer, no Only experimental implementation process is simple, is easy to test, and the cell component in every layer after layering is single, and it is thin to which thereby enhance single core The separative efficiency of born of the same parents.
According to an embodiment of the invention, the mononuclearcell is inoculated in the in vitro culture containing attached cell culture medium Equipment, further comprise to obtain attached cell:First, will be adherent thin using first with the mononuclearcell after PBS Born of the same parents' culture medium is cultivated 48 hours in 37 degrees Celsius of CO2gas incubator, first attached cell culture include low sugar- MEM, 15%FBS, 1 × nonessential amino acid, 10ng/mL bFGF and 30IU/mL heparin;Then, culture medium is replaced by second Attached cell culture medium continues to cultivate in 37 degrees Celsius of CO2gas incubator, and the second attached cell culture medium includes MEM- α, 15%FBS, 1 × nonessential amino acid and 10ng/mL bFGF.Thus, can be first by the mononuclearcell of separation Preliminary adaptability in vitro culture is carried out under suitable nutritional condition, the mononuclearcell is by the first patch containing low sugar-MEM After parietal cell medium culture 48 hours, culture medium is replaced by the second attached cell culture medium containing MEM- α and continues to cultivate, So as to obtain the good cell of adherence quality, and to grow up under microscope in spindle shape, its nucleus is larger, and growth is very fast, Therefore it is suitable for the experiment of handmade cloning body-cell neucleus transplanting.
According to an embodiment of the invention, the in vitro culture equipment is the coated culture dish of gelatin or the coated culture of gelatin Plate.Because gelatin is the major structural components of the extracellular matrix of multicellular organism, can promote the adherent of cell and increase Grow, specific morphological and functional expression, be usually used in the in vitro culture of the primary cell of various cells.Thus list can not only be improved Adherent efficiency of the individual nucleus in culture device, and compared with other adherent class reagents of rush, experimental cost is relatively low.
According to an embodiment of the invention, attached cell progress Secondary Culture is further comprised, will be described adherent thin Born of the same parents' Secondary Culture 2-20 generations.Thus, it is possible to it will enter in exponential phase, the mononuclearcell that activity is good, nucleus is larger One step is tested for handmade cloning body-cell neucleus transplanting.
Another object of the present invention is to provide a kind of method cloned to non-human animal, including:Using it is above-mentioned from The method for being separated in blood, cultivating cell, prepare the donorcells of somatic cell cloning;And based on the body-cell neucleus transplanting Donorcells, by handmade cloning, carry out clone non-human animal.Thus, it is possible to using it is according to embodiments of the present invention it is above-mentioned from The cell for separating, cultivating in blood, by handmade cloning, obtain non-human animal.Due to by it is according to embodiments of the present invention from The method of cell is separated, cultivated in blood, and not only experimental implementation process is simple, be easily achieved, cost is relatively low, and this method is to dynamic Thing stress stimulation is few, injury is small, it is ensured that the integral outer appearance of animal, improve animal welfare, therefore by the somatic cell nuclear of acquisition The donorcells of transplanting is used for non-human animal clone and had broad application prospects.
The additional aspect and advantage of the present invention will be set forth in part in the description, and will partly become from the following description Obtain substantially, or recognized by the practice of the present invention.
Brief description of the drawings
The above-mentioned and/or additional aspect and advantage of the present invention will become in the description from combination accompanying drawings below to embodiment Substantially and it is readily appreciated that, wherein:
Fig. 1 is the method schematic diagram for being separated from blood, cultivating cell according to the embodiment of the present invention.
Fig. 2 is the side that non-human cell clone is carried out using the cell being separately cultured from blood according to the embodiment of the present invention Method schematic diagram.
Fig. 3, which is shown, to be cultivated after pig vena cava anterior density gradient separation according to embodiments of the present invention after 7d by 200 times The cytological map that phase contrast microscope is observed.
Fig. 4, which is shown, to be cultivated after pig vena cava anterior density gradient separation according to embodiments of the present invention after 7d by 200 times The cytological map that phase contrast microscope is observed, which part cell grow in contact inhibition.
Fig. 5 show it is according to embodiments of the present invention from blood separate cell carry out adhere-wall culture be passaged to P1 generation pass through The cytological map that 100 times of phase contrast microscopes are observed.
Fig. 6 show it is according to embodiments of the present invention from blood separate cell carry out adhere-wall culture be passaged to P1 generation pass through The cytological map that 200 times of phase contrast microscopes are observed.
Fig. 7:Show that the cell according to embodiments of the present invention that will be separated, cultivate is used for body-cell neucleus transplanting, the 5th day logical Cross the blastaea aspect graph that 100 times of Huffman microscopes are observed.
Fig. 8:Show flow cytometric analysis results figure according to embodiments of the present invention:
8A is the surface markers fluidic cell result figure of CD29 egg mother cell;
8B is the surface markers fluidic cell result figure of CD90 egg mother cell;
8C is the surface markers fluidic cell result figure of CD34 egg mother cell;
8D is the surface markers fluidic cell result figure of CD45 egg mother cell.
Fig. 9 is the donorcells according to body-cell neucleus transplanting of the method based on the embodiment of the present invention of the embodiment of the present invention, And the non-human animal obtained by handmade cloning.
Embodiment
Embodiments of the invention are described below in detail, the example of the embodiment is shown in the drawings, wherein from beginning to end Same or similar label represents same or similar element or the element with same or like function.Below with reference to attached The embodiment of figure description is exemplary, it is intended to for explaining the present invention, and is not considered as limiting the invention.
In addition, term " first ", " second " are only used for describing purpose, and it is not intended that instruction or hint relative importance Or the implicit quantity for indicating indicated technical characteristic.Thus, define " first ", the feature of " second " can be expressed or Implicitly include one or more this feature.In the description of the invention, " multiple " are meant that two or more, Unless otherwise specifically defined.
The present invention is inventor based on the fact that finding:In recent years, cloned animal increasingly have its it is wide should With prospect, such as the cultivation available for high-quality poultry kind, to be advantageous to animals on the brink of extinction Germ-plasma resources protection;All kinds of experiments are produced to move Thing, being derived from experimental animal has the characteristics that inhereditary material homogeneity, phenotype uniformity, is more suitable for pharmacology items and grinds Study carefully;Clone is applied into transgenosis, can high efficiency obtain transgenic animals, shorten experimental period, largely obtain transgenic animals. During body-cell neucleus transplanting, donorcells species is various, including is filled between the embryonic stem cell with multipotency, fat Matter stem cell, and terminal differentiation cell fibroblast, liver cell, granular cell, liver cell etc..Derived from embryonic stem cells In the inner cell mass of blastula stage, generations up to a hundred can be exceeded by being cultivated on feeder cells, but cumbersome, be unsuitable for building on a large scale System's passage, and due to the particularity in its source, the relevant information of adult animal can not be obtained, clone and have for high-quality germline There is certain limitation;And the mescenchymal stem cell attached cell in bone source, mainly pass through the marrow in separating animal's femur And target cell is obtained, but the sample for using the method to collect is acquired, it is necessary to which animal is first put to death with facilitating;Other sources Be used for donor cell, tissue, organ wounds can be all caused to animal individual to varying degrees.It is at present the most normal into fiber Clone's cell somatic types, but for the big animal such as pig, ox, sheep, it is substantially and gathers its ear-edge tissue and carry out in vitro Original cuiture, but the reason such as growing environment factor due to itself, sample collection it is difficult to ensure that sterile, train in vitro by the later stage It is very high to support bacterium, the probability of fungal contamination in preparation process.
Thus in the first aspect of the invention, the present invention proposes a kind of method for being separated from blood, cultivating cell. This method comprises the following steps:By the blood be added to behind separating liquid upper strata using the mode of density gradient centrifugation carry out from The heart, to obtain mononuclearcell;The mononuclearcell is inoculated in the in vitro culture equipment containing attached cell culture medium, To obtain attached cell;And the attached cell is subjected to Secondary Culture, it is thin to obtain the donor of body-cell neucleus transplanting Born of the same parents.The donor of the body-cell neucleus transplanting prepared by the method according to embodiments of the present invention that cell is extracted, cultivated from blood Cell is used for handmade cloning body-cell neucleus transplanting, and blastaea efficiency is reaching as high as 55%, and average blastocyst rate is 40% or so.Thus, Not only operating process is simple for the method for being separated from blood, cultivating cell according to embodiments of the present invention, be easily achieved, cost compared with It is low, and this method is stimulated less Animal stress, injury is small, it is ensured that the integral outer appearance of animal, improve animal welfare.
Below in conjunction with the accompanying drawings 1 and embodiment to the present invention from blood separate, cultivate cell method do into One step describes in detail:
S101:Blood is added to behind separating liquid upper strata and centrifuged using the mode of density gradient centrifugation, to obtain Mononuclearcell
According to an embodiment of the invention, the mode for separating cell in blood is not particularly restricted, as long as can reach institute Using blood collection by the way of animal stimulated injure small purpose, blood collection method commonly used in the art can be used, According to some embodiments of the invention, blood collection can be carried out by modes such as tail vein, auricular veins, according to the one of the present invention Individual specific example, pig vena cava anterior blood mode can directly be extracted by using 50mL syringe from pig and extract periphery Blood.Due to peripheral blood acquisition operations are relatively easy, to Animal stress stimulate less, injury it is small, thus can not only improve animal good fortune Profit, and blood is comparatively closed with the external world, later stage pollution of cell culture rate is substantially zeroed, improves cell survival rate.
Embodiments of the invention, the mode preserved to the peripheral blood of above-mentioned acquisition are not particularly restricted, as long as can The peripheral blood that collection from obtaining to prevent solidifies before separating step is carried out, and can use anti-freezing mode commonly used in the art, root According to the specific embodiment of the present invention, it can use and heparin progress anti-freezing is added into the peripheral blood gathered.Inventor is surprised It was found that 125IU heparin is added in the peripheral blood gathered to 10mL can effectively prevent gathered periphery blood clotting.This Outside, according to an embodiment of the invention, the peripheral blood for adding heparin is placed in carrying out preserving transport under 4 degrees celsius.Thus, Gathered periphery blood clotting can be not only prevented, and can prevent the effective active cell component in peripheral blood from degrading, from And beneficial to the separation cell manipulation of next step.
Due to containing red blood cell, eosinophil, basophilic granulocyte, neutrophil leucocyte, T lymphocytes, B in blood Lymphocyte, NK, macrophage, monocyte, granulophilocyte, thick liquid cell, mast cell, blood platelet, The various cells such as mesenchymal cells, fibroblast, adipocyte and desmacyte, it is therefore desirable to above-mentioned cell is separated, The donorcells for extracting body-cell neucleus transplanting therefrom is used, so as to be used for handmade cloning.According to an embodiment of the invention, from blood The mode of middle separation mononuclearcell is not particularly restricted, and can use various cell separate modes commonly used in the art, root According to the specific example of the present invention, it can utilize and above-mentioned gathered peripheral blood is added into separating liquid upper strata and density gradient centrifugation Method separates to above-mentioned peripheral blood.Thus, it is possible to the mode of separating liquid and density gradient centrifugation is effectively utilized by blood Various cell components in liquid are separated according to the size of density, if being divided into dried layer by centrifugally operated blood, in every layer Containing different blood cell components, so as to effectively obtain mononuclearcell.
According to an embodiment of the invention, the used separating liquid separated to above-mentioned peripheral blood is not limited especially System, according to the specific example of the present invention, the separating liquid is neutrophil leucocyte separating liquid, the neutrophil leucocyte separating liquid it is close Spend for 1.077g/mL, and the specific composition for having the neutrophil leucocyte separating liquid is 57g/L ficolls and 90g/L amidotrizoic acids Sodium.Thus, the neutrophil leucocyte separating liquid containing mentioned component improves the separative efficiency of different cell components in separation blood, So as to effectively obtain the mononuclearcell in blood from the above-mentioned mononuclear cell layer by layering peripheral blood.According to this hair Bright embodiment, if blood constituent after centrifugation is divided into dried layer according to different density, point in test tube from top to bottom Layer includes but is not limited to plasma layer, cellular layer, separation liquid layer, neutrophil leucocyte layer, remaining separation liquid layer and erythroprecipitin Layer, wherein the mononuclearcell is in middle Yunfu shape cellular layer.According to an embodiment of the invention, collect separated single The method of nucleus is not particularly restricted, and can be various collection methods commonly used in the art, and specific according to the present invention is shown Example, can draw out using transfer pipet(te) by the mononuclearcell in middle Yunfu shape cellular layer, and further to drawing out The mononuclearcell come is cleaned, and according to a particular embodiment of the invention, the number of cleaning can be 2-3 times.Thus, it is possible to The separative efficiency to blood cell is improved, so as to obtain the mononuclearcell of high quality.
S102:Mononuclearcell is inoculated in vitro culture equipment, to obtain attached cell
According to an embodiment of the invention, the above-mentioned mononuclearcell isolated and cleaned is inoculated in containing attached cell The in vitro culture equipment of culture medium, to obtain attached cell.According to an embodiment of the invention, the mononuclearcell to isolating The mode for carrying out in vitro culture is not particularly restricted, can be with as long as can cause the adherent normal growth of above-mentioned mononuclearcell Using various extracorporeal culturing methods commonly used in the art, according to some embodiments of the present invention, first by through the single of over cleaning Nucleus is cultivated 48 hours using the first attached cell culture medium in 37 degrees Celsius of CO2gas incubator.According to the present invention Embodiment, the composition of the first attached cell culture medium is not particularly limited, as long as containing enough nutrition and being adapted to The mononuclearcell just separated from blood carries out adherent growth in culture device in vitro, can use commonly used in the art Various adhere-wall culture bases, according to a particular embodiment of the invention, the first attached cell culture medium can include low sugar-MEM, 15%FBS, [1 ×] nonessential amino acid, 10ng/mL bFGF and 30IU/mL heparin.According to some embodiments of the present invention, 48 The first attached cell culture medium is replaced by titanium dioxide of the second attached cell culture medium continuation at 37 degrees Celsius after hour Cultivated in carbon incubator, the second attached cell culture medium volume can include MEM- α, 15%FBS, [1 ×] nonessential amino acid With 10ng/mL bFGF.Wherein, according to an embodiment of the invention, the first attached cell culture medium is changed after 48 hours Mode for the second attached cell culture medium is not particularly restricted, can be first by described the according to the specific example of the present invention One attached cell culture medium discards, and then cell is cleaned using PBS to remove the culture of the first attached cell of residual Base, then the second attached cell culture medium is added in adherent mononuclearcell and continues to cultivate, according to the present invention Embodiment, the number of cleaning can be 1-2 times.Wherein, MEM- α are a kind of MEM culture mediums of improvement, with the addition of it is a variety of it is non-must Need amino acid and Anacobin, C etc.;And can promote cell attachment using low sugar-MEM, using MEM- α after 48h instead can be reduced Adherent haemocyte, so as to be advantageous to adherent karyocyte growth.Thus, the mononuclearcell by separation can exist first Preliminary adaptability in vitro culture is carried out under suitable nutritional condition(Utilize the first attached cell culture medium containing low sugar-MEM Culture 48 hours), culture medium is replaced by be more suitable for the second attached cell culture medium containing MEM- α of adherent growth after Continuous culture, so that the above-mentioned mononuclearcell separated from peripheral blood can form suitable and abundance in nutritional ingredient Adhere-wall culture base in carry out appropriate growth.
According to an embodiment of the invention, used in vitro culture equipment is not particularly restricted, as long as being adapted to from blood In the mononuclearcell growth isolated, various culture devices commonly used in the art can be used and be selected as needed, Such as 35mm culture dishes, 60mm culture dishes, 100mm culture dishes, 6 orifice plates and 4 orifice plates, according to the specific example of the present invention, adopted In vitro culture can be the coated culture dish of gelatin or the coated culture plate of gelatin.Because gelatin is multicellular organism Extracellular matrix major structural components, the adherent of cell and propagation, specific morphological and functional expression can be promoted, commonly used In the in vitro culture of the primary cell of various cells.Thus adherent effect of the mononuclearcell in culture device can not only be improved Rate, and reduce experimental cost.According to an embodiment of the invention, using and attached cell culture medium to adherent single core The mode that cell is cultivated is not particularly restricted, and according to the specific example of the present invention, can once be changed using 2-3 days Liquid is operated so as to keep adherent mononuclearcell to be in the suitable and sufficient attached cell culture medium of nutritional ingredient all the time In grown.The mononuclearcell adherence quality that method according to embodiments of the present invention obtains is good, and growth is very fast, under microscope Grow up in spindle shape, its entoblast is larger and high-visible, therefore is suitable for handmade cloning body-cell neucleus transplanting(See figure 3).
S103:Attached cell is subjected to Secondary Culture, to obtain the donorcells of body-cell neucleus transplanting
According to an embodiment of the invention, when adherent mononuclearcell fills into bulk contact inhibition to be grown(See Fig. 4), can To carry out passage culture., can be by the attached cell Secondary Culture 2-20 generations according to the specific example of the present invention.According to Embodiments of the invention, by above-mentioned in a manner of bulk contact inhibition fills the adherent mononuclearcell progress Secondary Culture of growth It is not particularly restricted, can is various propagating methods commonly used in the art, according to the specific example of the present invention, can uses such as Lower step:Discard former culture medium;Add PBS rinse cell 2 times;Cell dissociation buffer is added after discarding PBS Cell, and cell is positioned in 37 degrees Celsius of CO2gas incubator and digested;Add adhere-wall culture base 2 and with warp The mononuclearcell for crossing digestion is well mixed, to obtain cell suspension;Above-mentioned cell suspension is transferred to and is coated with by gelatin Culture device in carry out Secondary Culture.Mononuclearcell is obtained by the method for the cultured cell line of the embodiment of the present invention to give birth to Length is vigorous, and proliferative is good(See Fig. 5 and Fig. 6).Wherein, according to an embodiment of the invention, used digestive juice is not by special Limitation, if under the microscope observation can cause attached cell is gradually rounded to brighten, and progressively disengage cell cultivation equipment from And float in cell dissociation buffer, various cell dissociation buffers commonly used in the art can be used, according to the specific implementation of the present invention Example, cell dissociation buffer can be 0.05% pancreatin -200mg/L EDTA.Thus, it is possible to will be in exponential phase, activity it is good, The larger mononuclearcell of nucleus is further used for the experiment of handmade cloning body-cell neucleus transplanting.
In another aspect of this invention, the invention provides a kind of method cloned to non-human animal, including:Utilize The above-mentioned method for being separated from blood, cultivating cell, prepare the donorcells of somatic cell cloning;And based on the somatic cell nuclear The donorcells of transplanting, by handmade cloning, carry out clone non-human animal.Thus, it is possible to utilize according to embodiments of the present invention The above-mentioned cell for separating, cultivating from blood, by handmade cloning, obtain non-human animal.Due to by being implemented according to the present invention Not only experimental implementation process is simple for the method for being separated from blood, cultivating cell of example, be easily achieved, cost is relatively low, and the party Method is stimulated less Animal stress, injury is small, it is ensured that the integral outer appearance of animal, improve animal welfare, therefore by the body of acquisition The donorcells of nuclear transplantation is used for non-human animal clone and had broad application prospects.
Below in conjunction with the accompanying drawings 2 and embodiment the present invention is carried out using the cell that is separately cultured from blood it is non- The method of people's cell clone is described in further details:
S201:Oocyte IVM and surface molecular identification
According to an embodiment of the invention, the mode of oocyte collection is not particularly restricted, as long as health can be obtained Egg cell, can use various methods commonly used in the art, according to a particular embodiment of the invention, following step can be included Suddenly:The ovary of collection is placed in the container equipped with physiological saline and keeps 35 degrees Celsius of constant temperature;Then above-mentioned ovary is put It is placed in the culture dish equipped with embryo's cleaning solution, is scratched ovarian follicle using blade, so that egg cell flows out;And will be above-mentioned Egg cell is collected in the culture device containing egg cell culture medium of pre-balance and cultivated to egg maturation.According to the present invention Embodiment, egg cell culture to the condition of maturation is not particularly limited, can be that various egg cells commonly used in the art are trained The technology of supporting, according to the specific example of the present invention, in order to reach the metastable culture environment of pH value, culture medium is placed in advance The CO2gas incubator of 5% concentration is balanced, and then contains embryo maturation culture medium by what egg cell was collected in pre-balance (IVM)In four orifice plates, each 50 embryos in hole, and the above-mentioned four hole versions for being loaded with egg cell are placed in 38.5 degrees Celsius of titanium dioxide Ripe 42h in carbon incubator.According to an embodiment of the invention, above-mentioned embryo's cleaning solution is not particularly restricted, and can be ability The conventional various liquid washed to embryo in domain, according to the specific example of the present invention, used embryo's cleaning solution(ASP) In include:10%v/v 10 × TCM199,0.17mg/mL sodium acid carbonate, 0.20mg/mL Sodium Pyruvate, 3.60mg/mL are conspicuous Wear this sodium salt, 2.63mg/mL He Peisi acid, 0.20mg/mL glutamine, 3.00 μ g/mL amphotericin B, 30IU/mL Heparin, 2% serum.Thus, it is possible to the fragment in ovary cut substrate is removed, so as to reduce the pollution of cultivated aim cell Probability, improve cell survival rate.
According to an embodiment of the invention, embryo maturation culture medium(IVM)It is not particularly restricted, can is commonly used in the art The culture medium cultivated embryo, according to the present invention instantiation, used embryo maturation culture medium(IVM)Bag Contain:TCM199, the 5IU/mL of [1 ×] human chorionic gonadotrophin, 1IU/mL pregnant mare serum, 0.10mg/mL paddy ammonia Acid amides, 0.05mg/mL gentamicins, 10% liquor folliculi, 10%v/v serum.Thus, passed through by making egg cell in the culture medium The culture of 42 hours, the maturation of egg mother cell can be promoted, first polar body be discharged, so as to improve into heat efficiency(First polar body is arranged Extracting rate), approximately more than 80%.
According to an embodiment of the invention, the method identified the egg mother cell obtained is not particularly limited, can be with For various cellular identification methods commonly used in the art, including but not limited to cell surface molecule labelling method, flow cytometry etc..Root According to the specific embodiment of the present invention, CD29, CD90, CD34, CD45, FITC Mouse IgG1 and PE Mouse IgG17 are utilized Kind different antibody carries out surface markers to the egg mother cell obtained, then using BD FACSCalibur flow cytometers with And WinMDI2.8 softwares are analyzed, to determine whether obtained cell is mescenchymal stem cell.
S202:Egg mother cell takes off ovarian cumulus and stoning
By the ripe egg cell of above-mentioned culture from containing embryo maturation culture medium(IVM)Four orifice plates in be transferred to hyalomitome In sour enzyme, to slough cumulus granulosa cells.According to an embodiment of the invention, will cultivate ripe egg cell from containing embryo into Ripe culture medium(IVM)Four orifice plates in the transfer operation that is transferred in hyaluronidase be not particularly restricted, can be ability The technology of the conventional transfer egg cell in domain, it is according to a particular embodiment of the invention, using liquid-transfering gun that ripe complete ovum is female thin Born of the same parents are from containing embryo maturation culture medium(IVM)Four orifice plates in into hyaluronidase.Wherein, according to an embodiment of the invention, The concentration of used hyaluronidase is not particularly restricted, as long as cumulus granulosa cells, people in the art can be sloughed Member can carry out appropriate regulation according to the concentration of cell and the species of reagent, according to a particular embodiment of the invention, be adopted The concentration of hyaluronidase can be 1mg/mL.Hyaluronidase main function is hyaluronic acid between dissolving cumulus cell, So that cumulus cell disperses, thus, it is possible to using appropriate concentration by the cumulus cell in the ripe egg cell of above-mentioned culture Disperse further to remove.According to an embodiment of the invention, the operation for sloughing cumulus granulosa cells is not particularly restricted, can To use various technologies commonly used in the art, according to the specific implementation of present invention profit, inventor has surprisingly found that, using with rifle The liquid-transfering gun of head carrys out resorption and beats the hyaluronidase containing egg mother cell, egg cell can be entered repeatedly using the small-bore of pipette tips Row, which is inhaled, to be beaten, so as to slough the cumulus granulosa cells that mature egg pericellular carries out being metabolized therewith contact.
According to an embodiment of the invention, the method for removing ootid nucleus is not particularly restricted, and can be commonly used in the art Various pitting methods, according to the present invention instantiation, can be first by the above-mentioned exposed egg mother cell for eliminating cumulus cell It is positioned in protease, it is loose so as to which the oolemma on egg mother cell top layer is digested, it is then transferred to the second embryo operation In liquid operation drop, and the method positioned according to polar body, first polar body is cut off together with part egg mother cell matter.According to the present invention's Embodiment, the second embryo operation liquid can the sodium acid carbonate including 10%v/v [10 ×] TCM199,0.17mg/mL, 0.20 Mg/mL Sodium Pyruvate, 3.60mg/mL He Peisi sodium salts, 2.63mg/mL He Peisi acid, 0.20mg/mL glutamy Amine, 2.5 μ g/mL B cytochalasin Bs and 20% serum.Thus, it is possible to effectively remove oocyte nuclei.
According to an embodiment of the invention, placement is above-mentioned is not particularly restricted by the mode of non-nucleus egg mother cell, this Art personnel can need to be selected according to subsequent operation, according to the specific example of the present invention, by the ovum of above-mentioned stoning Mother cell is transferred to stand-by in the first embryo operation liquid operation drop.According to an embodiment of the invention, the first embryo operation liquid can be with [10 ×] TCM199,0.17mg/mL sodium acid carbonate, 0.20mg/mL Sodium Pyruvate, 3.60mg/mL including 10%v/v He Peisi acid, 0.20mg/mL glutamine, 2% serum of He Peisi sodium salts, 2.63mg/mL.Thus, the process obtained Non-nucleus egg mother cell is survived in containing most suitable embryo operation pendular ring border.
S203:Egg mother cell merges with donorcells
According to an embodiment of the invention, the body cell obtained in S103 is scattered in into above-mentioned first embryo operation liquid first to grasp In dripping, thus, body cell is in the first embryo operation liquid operation drop in individual cells distribution shape;Then will be obtained in S202 Above-mentioned the first embryo containing body cell is transferred to after non-nucleus egg mother cell places a period of time in phytolectin In tire operation liquid operation drop, wherein according to some instantiations of the present invention, it is female thin by the ovum being enucleated by being obtained in S202 Born of the same parents place 1~2 second in 1mg/mL phytolectins, it is possible thereby to make cytosolic surface band toughness, so that single body is thin Born of the same parents and process non-nucleus egg mother cell are sufficiently bonded in the first embryo operation liquid operation drop.
According to an embodiment of the invention, by non-nucleus egg mother cell(Kytoplasm)The method merged with donorcells is not It is particularly limited, can is various cell-fusion techniques commonly used in the art, can be by born of the same parents according to the specific example of the present invention Matter-body cell, which is transferred to, to be loaded with the integration slot of mixing operation liquid, is merged by electric shock.According to an embodiment of the invention, Mixing operation liquid in integration slot can include 3M mannitol, 1mg/mL polyvinyl alcohol and 0.1mM magnesium sulfate.Thus egg mother cell It may be in most suitable environmental condition receiving electric shock with body cell, so as to improve fusion efficiencies.According to the implementation of the present invention Example, the condition merged to egg mother cell-body cell are not particularly restricted, and those skilled in the art can be according to specific thin Born of the same parents' situation and equipment situation are adjusted, according to an embodiment of the invention, the bar that electric shock egg mother cell is merged with body cell Part can be 100V direct currents electric shock 9 μ s, 4V alternating currents electric shock.It can depolarize kytoplasm by using alternating current, so as to It is set to hang on wire electrode, and by electric pulse, cell membrane can be made to form an instantaneous perforation, so that kytoplasm With donorcells film combination and merging.Thus, kytoplasm can receive electric shock with body cell under conditions of being best suitable for, so as to obtain Sufficiently fusion, to obtain reconstruct clone embryos.According to an embodiment of the invention, the cell to have shocked by electricity is transferred to embryo behaviour Make in the operation drop of liquid 1, and operation panel is placed in 38.5 degrees Celsius of thermal station and waited 1 hour, so as to improve late embryogenesis development Efficiency.
S204:Reconstructed embryo is activated, forms embryo
According to an embodiment of the invention, it will be transferred to by the kytoplasm for having body cell that melts obtained in S203 steps and be loaded with activation In the integration slot for operating liquid, and stoning ovum mother's kytoplasm obtained in S202 steps is hung, then shocked by electricity.Wherein utilize Alternating current depolarizes reconstructed embryo so that it can be hung on wire electrode, second kytoplasm be also by unpolarizing, can So that it can be contacted with reconstructed embryo.Pass through the above method so that an individual cells have merged two kytoplasms, and the composition of kytoplasm increases Add, more nutriments can be provided, be advantageous to the embryonic development in later stage.According to an embodiment of the invention, above-mentioned activation manipulation Liquid can be 3M mannitol, 1mg/mL polyvinyl alcohol, 0.1mM magnesium sulfate and 0.05mM calcium chloride.
According to an embodiment of the invention, the condition to be shocked by electricity is not particularly restricted, and those skilled in the art can root It is adjusted according to specific cell situation and equipment situation, according to the instantiation of the present invention, the condition of electric shock can be 43V direct currents Electricity 80 μ s of electric shock, are then shocked by electricity using 4V alternating currents.Thus, it can depolarize reconstructed embryo by using alternating current, so as to It is set to hang on wire electrode, and by electric pulse, cell membrane can be made to form an instantaneous perforation, so that reconstruct Embryo and cytoplasmic cell film combination simultaneously merge;Then the embryo transfer after electric shock is treated two into the first embryo operation liquid operation drop Individual cytomixis.Thus, it is possible to improve the stability of embryo.
According to an embodiment of the invention, the mode for entering line activating to the above-mentioned cell by fusion is unrestricted, can Think various activation techniques commonly used in the art, according to a particular embodiment of the invention, the embryo by fusion is subjected to chemistry Activation, wherein according to the instantiation of the present invention, chemokinesis is carried out during the embryo transfer by fusion to chemokinesis is dripped. According to some embodiments of the present invention, the above-mentioned chemically sensitized chemokinesis drop of carry out contains embryo culture medium(IVC)And 5 μ G/mL B cytochalasin B, 10 μ g/mL cycloheximide.According to an embodiment of the invention, embryo culture medium(IVC)It can include 6.31mg/mL sodium chloride, 2.11mg/mL sodium acid carbonate, 0.75mg/mL potassium chloride, 0.05mg/mL biphosphate The meso of potassium, 0.05mg/mL magnesium sulfate, 0.62mg/mL calcium lactate, 0.02mg/mL Sodium Pyruvate, 0.50mg/mL Inositol, 0.01g/mL phenol red, 0.05mg/mL glutamine, 0.55mg/mL sub- ox acid iodide, 0.04mg/mL celebrating are mould greatly Element, 3g/L bovine serum albumin(BSA), the nonessential amino acid and the essential amino acid of [0.5 ×] of [1 ×].It is possible thereby on so that The cell by fusion is stated to be activated in most suitable medium component.According to other embodiments of the present invention, will pass through It is in 38.5 degrees Celsius, 5% carbon dioxide and 5% oxygen culture that the embryo transfer of fusion, which carries out chemokinesis into embryo culture medium, Carried out in case.According to the specific example of the present invention, taken the photograph by the embryo transfer by fusion into embryo culture medium and 38.5 Cultivated 4 hours in family name's degree, 5% carbon dioxide and 5% oxygen incubator.Thus, it is possible to so that the above-mentioned cell by activation is most It is adapted to carry out adaptability growth under the environmental condition of growth, so as to improve survival rate of embryo.
According to an embodiment of the invention, by the above-mentioned embryo grown by activation and adaptability from above-mentioned chemokinesis drips It is transferred in four orifice plates containing embryo culture medium of punching, and in 38.5 degrees Celsius, 5% carbon dioxide and 5% oxygen incubator Continue to cultivate 120h or 144h.By punching multiple lensless Fourier transform holography reconstructed embryos can be made to be cultivated in same fluid apertures, It is each to have oneself independent developmenting space by oneself, and close information can occur in same fluid apertures and exchange, be advantageous to embryonic development. Thus, the above-mentioned embryo by activation and adaptability growth further can be grown under suitable conditions and environment, from And improve the survival rate of embryo.
S205:Embryonic limb bud cell
According to an embodiment of the invention, the above-mentioned Embryonic limb bud cell by vitro culture is treated into pregnant animal fallopian tubal or uterus It is interior, clone non-human animal by enough pregnancy periods.According to an embodiment of the invention, the above-mentioned embryo by vitro culture is planted Enter to treat that pregnant animal fallopian tubal or intrauterine mode are not particularly restricted, can be the Embryonic limb bud cell skill that this area usually uses Art, according to a particular embodiment of the invention, the blastaea to 120h will be developed(See Fig. 7)Enter to treat the son of pregnant parent by operation transplantation In the angle of palace.According to an embodiment of the invention, embryo develops 114 days or so in parent, passes through spontaneous labor or output of cutting open the belly Non-human animal is cloned, birth animal sees Fig. 9.
Embodiment 1 obtains mononuclearcell from blood
In advance into 15mL conical centrifuge tube add 125IU heparin, and by concussion make its be uniformly distributed in taper from The tube wall of heart pipe.Pig vena cava anterior blood mode is directly extracted by the peripheral blood of miniature pig about 12mL by using 50mL syringe It is collected in the above-mentioned conical centrifuge tube for adding heparin 15mL.The conical centrifuge tube for being loaded with peripheral blood is placed in 4 degrees Celsius Transport can laboratory in ice chest.
Two 15mL conical centrifuge tube separately is taken, and is separately added into 5mL neutrophil leucocyte separating liquid thereto(Contain 57g/L ficolls and 90g/L Sodium Amidotrizoates)Afterwards, using liquid-transfering gun carefully along 15mL conical centrifuge tube wall and press close to neutrality Granulocyte separating liquid liquid level is slowly added to the 5mL anticoagulation cirumferential blood gathered, and ensure the anticoagulation cirumferential blood not with lower floor Neutrophil leucocyte separating liquid mixes, then horizontal centrifugal 30 minutes under the conditions of 400g.
After centrifugation, intermediate layer Yunfu shape mononuclearcell is collected from two centrifuge tubes respectively using liquid-transfering gun, and merge and put It is placed in new 50mL conical centrifuge tube.By 20mL PBS be added to the foregoing taper containing mononuclearcell 50mL from In heart pipe, and blown and beaten and cleaned repeatedly using Pasteur's dropper.After cleaning, the PBS suspensions containing mononuclearcell are existed Centrifuged 10 minutes under the conditions of 300g.After centrifugation, 50mL conical centrifuge tube is taken out, remove after supernatant again to thin containing single core 20mL PBS is added in the 50mL of born of the same parents' precipitation conical centrifuge tube, and reuses Pasteur's dropper and blows and beats second of progress repeatedly Cleaning.After second is cleaned, the PBS suspensions containing mononuclearcell are centrifuged 10 minutes under the conditions of 300g again.Then Above-mentioned second of cleaning step is repeated, third time cleaning is carried out to mononuclearcell.
The mononuclearcell in vitro culture of embodiment 2
What is obtained into embodiment 1 adds 2mL after 3 times are cleaned and discarded and centrifuged in the cell precipitation of PBS supernatants Containing low sugar-MEM, 15%FBS, [1 ×] nonessential amino acid, 10ng/mL bFGF and 30IU/mL heparin the first attached cell Culture medium, and mononuclearcell precipitation piping and druming is dispersed in the first attached cell culture medium using Pasteur's dropper.It will contain There is the first attached cell media transfer of mononuclearcell into the coated 35mm culture dishes of gelatin, it is Celsius to be then placed within 37 Cultivated in the CO2gas incubator of degree.
By the culture of 48 hours, taken out to the 35mm culture dishes for being loaded with mononuclearcell from incubator, discard first After attached cell culture medium, add PBS and rinsed.After discarding PBS, added into the 35mm culture dishes for being loaded with mononuclearcell The second attached cell culture medium containing MEM- α, 15%FBS, [1 ×] nonessential amino acid and 10ng/mL bFGF, and will culture Ware puts back to incubator and continues to cultivate.And the 35mm culture dishes for being loaded with mononuclearcell were adopted respectively at the 72nd and 96 hour Carried out changing liquid processing with the second attached cell culture medium.After mononuclearcell culture 5-7 days, light microscope progress is placed in Observe, mononuclearcell is in into fibrous adherent cell growth on culture dish bottom surface under mirror(See Fig. 3), and nucleus is larger, Entoblast is high-visible.
The Secondary Culture of the mononuclearcell of embodiment 3
When adherent mononuclearcell is observed under the microscope fills growth in bulk contact inhibition(See Fig. 4), discard training Support the second attached cell culture medium in ware;Then PBS rinse cell is added 2 times;After discarding PBS, to being loaded with 200 μ L0.05% pancreatin -200mg/L EDTA are added in the culture dish of adherent mononuclearcell, and cell is positioned over 37 and taken the photograph Digested in the CO2gas incubator of family name's degree, brighten and gradually take off when observing that attached cell is gradually rounded under the microscope When being floated on from culture dish in cell pancreatin, 1mL the second attached cell culture mediums are added into culture dish, and drip by Pasteur Pipe, which is blown and beaten, causes mononuclearcell to be well mixed with the fresh second attached cell culture medium added, to obtain cell suspension; Then above-mentioned cell suspension is transferred to by carrying out Secondary Culture in the coated culture device of gelatin.Entered the patch of Secondary Culture Wall mononuclearcell is observed under the microscope, and cell late growing stage is vigorous, and proliferative is good(See Fig. 5 and Fig. 6).By Secondary Culture 2-20 be moved directly to for mononuclearcell cell suspension it is stand-by in 1.5mL centrifuge tubes, for handmade cloning.
The oocyte IVM of embodiment 4 and surface molecular identification
The pig ovary collected from slaughterhouse is placed in the container equipped with physiological saline to keep osmotic balance, and with 35 degrees Celsius of constant temperatures transport go back to laboratory.Ovary is positioned over equipped with embryo's cleaning solution(ASP)Culture dish in(Wherein embryo Tire cleaning solution(ASP)The sodium acid carbonate of 10 × TCM199,0.17mg/mL containing 10%v/v, 0.20mg/mL Sodium Pyruvate, 3.60mg/mL He Peisi sodium salts, 2.63mg/mL He Peisi acid, 0.20mg/mL glutamine, 3.00 μ g/mL both sexes are mould Plain B, 30IU/mL heparin, 2% serum), ovarian follicle is scratched to cause the egg cell in ovarian follicle to flow out with blade.In order to reach The metastable culture environment of pH value, the CO2gas incubator that culture medium is placed on to 5% concentration in advance are balanced, then By the egg cell of outflow with the density collection of every 50 embryos in hole in the embryo maturation culture medium of pre-balance(IVM)Four orifice plates In, wherein embryo maturation culture medium(IVM)Human chorionic gonadotrophin, the 1IU/mL of TCM199,5IU/mL containing [1 ×] Pregnant mare serum, 0.10mg/mL glutamine, 0.05mg/mL gentamicins, 10% liquor folliculi, 10%v/v serum.Then will Four orifice plates for being loaded with embryo are placed in 38.5 degrees Celsius of CO2gas incubators and cultivate 42h to maturation.
Adherent mature oocyte is subjected to digestion process, and centrifuged 3 minutes under the conditions of 350g, abandoning supernatant Afterwards, 2mL PBS are added into precipitation and carries out piping and druming washing;Then again with 350g centrifuge 3 minutes, abandoning supernatant backward from Precipitation in heart pipe adds 700 μ L PBS, and resulting suspension mean allocation is added into 7 new 2mL after piping and druming mixing In centrifuge tube, i.e., often pipe adds 100 μ L cell suspending liquids;Then the μ L antibody 7 of 5 μ L~20 is added into each centrifuge tube respectively Individual different antibody:CD29, CD90, CD34, CD45, FITC Mouse IgG1 and PE Mouse IgG1, vortex fully mix Afterwards, lucifuge is incubated 15 minutes;Then 2 washings are carried out to the cell that marked surface antigen, condition is to add 1mL PBS, Shake up and down it is even after with 350g centrifuge 3 minutes, abandon supernatant;Then again with 0.4mL poly methanol(4% concentration is dissolved in PBS)Dissolving washing Cell precipitation afterwards, upper machine analysis is carried out to it using BD FACSCalibur, result is read using WinMDI2.8 softwares Take, as a result referring to Fig. 8.Fig. 8 shows the high expression CD29 and CD90 surface antigens of cell according to embodiments of the present invention, without table Up to CD34 and CD45 surface antigens.Fig. 8 result shows the high expression CD29 and CD90 surface antigens of obtained egg mother cell, no CD34 and CD45 surface antigens are expressed, the CD29 and CD90 of the egg mother cell obtained in it positive rate are respectively 99.27% He 98.62, and CD34 and CD45 positive rate is respectively 0.43% and 0.45%.
The porcine oocytes of embodiment 5 take off ovarian cumulus and stoning
By the ripe egg cell liquid-transfering gun of above-mentioned culture from containing embryo maturation culture medium(IVM)Four orifice plates in shift Into 1mg/mL hyaluronidases, with pipette tips come resorption since and slough cumulus granulosa cells.Then first ovum is eliminated by above-mentioned The exposed egg mother cell of mound cell is positioned in protease, loose so as to which the oolemma for being covered in egg mother cell top layer is digested, Then transfer them in the second embryo operation liquid operation drop, and the method positioned according to polar body, by first polar body together with part Egg mother cell matter is cut off.Non-nucleus egg mother cell is transferred to it is stand-by in first embryo operation liquid operation drop, so as to be obtained It can be survived by non-nucleus egg mother cell in containing most suitable embryo operation pendular ring border.Wherein the first embryo operation liquid can With the sodium acid carbonate of [10 ×] TCM199,0.17mg/mL including 10%v/v, 0.20mg/mL Sodium Pyruvate, 3.60mg/mL He Peisi sodium salts, 2.63mg/mL He Peisi acid, 0.20mg/mL glutamine, 2% serum.
The egg mother cell of embodiment 6 merges with donorcells
The body cell that embodiment 3 obtains is placed in the first embryo operation liquid operation drop, and causes body cell in the behaviour In individual cells distribution shape in dripping.Pass through non-nucleus egg mother cell in 1mg/mL phytolectins by what embodiment 5 obtained Place 1 second~2 seconds, the body cell then obtained with above-described embodiment 3, which merges to be put into foregoing first embryo operation liquid to operate, to drip In, so that single body cell and process non-nucleus egg mother cell are sufficiently pasted in the first embryo operation liquid operation drop Close.By enucleation oocyte(Kytoplasm)- body cell, which is transferred to, to be loaded with the integration slot of mixing operation liquid, is melted by electric shock Close, to obtain reconstruct clone embryos.Mixing operation liquid wherein in integration slot include 3M mannitol, 1mg/mL polyvinyl alcohol and 0.1mM magnesium sulfate.The condition that electric shock egg mother cell is merged with body cell is 100V direct currents electric shock 9 μ s, 4V alternating currents electricity Hit.Shocked by electricity all egg mother cells and body cell successively, transfers it in the first embryo operation liquid operation drop, will grasp It is placed in 38.5 degrees Celsius of thermal station and waits 1 hour as disk.
Embodiment 7 activates reconstructed embryo, forms embryo
According to an embodiment of the invention, the kytoplasm that has body cell will be melted in embodiment 6 it is transferred to and is loaded with activation manipulation liquid In integration slot(Wherein activation manipulation liquid contains 3M mannitol, 1mg/mL polyvinyl alcohol, 0.1mM magnesium sulfate and 0.05mM Calcium chloride), and the stoning kytoplasm obtained in embodiment 5 is hung, then shocked by electricity, to make reconstructed embryo and cytomixis: Wherein depolarize reconstructed embryo using alternating current, so that it can be hung on wire electrode, second kytoplasm is also by going to pole Change is acted on, and it can be made to be contacted with reconstructed embryo.The condition of electric shock is 43V direct currents 80 μ s of electric shock, then using 4V alternating currents Electric shock, 4V alternating currents are until electric shock is closed after terminating.Thus, it can depolarize reconstructed embryo by using alternating current, so as to So that it can be hung on wire electrode, and by electric pulse, cell membrane can be made to form an instantaneous perforation, so that weight Structure embryo and cytoplasmic cell film combination simultaneously merge;Then the embryo transfer after electric shock is treated into the first embryo operation liquid operation drop Two cytomixis.
Chemokinesis, the above-mentioned chemically sensitized chemistry of carry out are carried out during embryo transfer by fusion to chemokinesis is dripped Activation drop contains embryo culture medium(IVC)And 5 μ g/mL B cytochalasin B and 10 μ g/mL cycloheximide.Wherein, embryo Culture medium(IVC)The sodium acid carbonate of sodium chloride, 2.11mg/mL comprising 6.31mg/mL, 0.75mg/mL potassium chloride, 0.05mg/mL potassium dihydrogen phosphate, 0.05mg/mL magnesium sulfate, 0.62mg/mL calcium lactate, 0.02mg/mL pyruvic acid Sodium, 0.50mg/mL meso inositol, 0.01g/mL phenol red, 0.05mg/mL glutamine, 0.55mg/mL sub- ox iodine Acid, 0.04mg/mL gentamicin, 3g/L bovine serum albumin(BSA), [1 ×] nonessential amino acid and [0.5 ×] it is required Amino acid.To through embryo transfer fusion into embryo culture medium in 38.5 degrees Celsius, 5% carbon dioxide and 5% oxygen culture Chemokinesis is carried out in case, activationary time is 4 hours.
Punching is transferred to during the above-mentioned embryo by activation with adaptability growth is dripped from above-mentioned chemokinesis contains embryo In four orifice plates of culture medium, and continue culture 120h in 38.5 degrees Celsius, 5% carbon dioxide and 5% oxygen incubator.
The Embryonic limb bud cell of embodiment 8
The above-mentioned Embryonic limb bud cell by vitro culture treats pregnant animal fallopian tubal or intrauterine, is cloned by enough pregnancy periods Non-human animal.The blastaea to 120h will be developed first(See Fig. 7)Entered by operation transplantation in the cornua uteri for treating pregnant sow body.Embryo Tire, by internal development 114 days or so, clones non-human animal, birth animal sees figure in sow by spontaneous labor or output of cutting open the belly 9。
In the description of this specification, reference term " one embodiment ", " some embodiments ", " example ", " specifically show The description of example " or " some examples " etc. means specific features, structure, material or the spy for combining the embodiment or example description Point is contained at least one embodiment or example of the present invention.In this manual, to the schematic representation of above-mentioned term not Necessarily refer to identical embodiment or example.Moreover, specific features, structure, material or the feature of description can be any One or more embodiments or example in combine in an appropriate manner.
Although embodiments of the invention have been shown and described above, it is to be understood that above-described embodiment is example Property, it is impossible to limitation of the present invention is interpreted as, one of ordinary skill in the art is not departing from the principle and objective of the present invention In the case of above-described embodiment can be changed within the scope of the invention, change, replace and modification.

Claims (1)

  1. A kind of 1. method for the donorcells for being separated from blood, cultivating body-cell neucleus transplanting, it is characterised in that including following step Suddenly:
    (1) 12mL peripheral bloods are collected in the centrifuge tube equipped with 125IU heparin, mix, obtain anticoagulation cirumferential blood;
    (2) it is 1.077g/mL to the density equipped with 5mL, the neutrophil leucocyte containing 57g/L ficolls and 90g/L Sodium Amidotrizoates Anticoagulation cirumferential blood described in adding 5mL in separating liquid, ensures that neutrophil leucocyte separating liquid of the anticoagulation cirumferential blood not with lower floor is mixed Close, then horizontal centrifugal 30 minutes under the conditions of 400g, collect intermediate layer Yunfu shape mononuclearcell;
    (3) repeat step (2) once, and intermediate layer Yunfu shape mononuclearcell resulting twice is incorporated in centrifuge tube;
    (4) 20mL PBSs are added into step (3) described centrifuge tube, are purged, and 10 are centrifuged under the conditions of 300g Minute, collect precipitation;
    (5) by the operation 2 times of the precipitation repeat step (4), precipitation is collected, obtains mononuclearcell;
    (6) mononuclearcell is inoculated in containing low sugar-MEM, 15%FBS, 1 × nonessential amino acid, 10ng/mL First attached cell culture medium of bFGF and 30IU/mL heparin, and the first attached cell containing the mononuclearcell is trained Group-transfer is supported into the coated 35mm culture dishes of gelatin, is then placed within 37 degrees Celsius of CO2gas incubator and is trained Support;
    When culture to 48,72 and 96 hours when, by culture medium be replaced by containing MEM- α, 15%FBS, 1 × nonessential amino acid and 10ng/mL bFGF the second attached cell culture medium, continues to cultivate in 37 degrees Celsius of CO2gas incubator, culture 5 ~7 days, obtain attached cell;
    (7) attached cell 2 times described in PBS rinse are used, after discarding PBS, to the training for being loaded with the attached cell Support in ware and add the pancreatin -200mg/L EDTA of 200 μ L 0.05%, be placed in carrying out in 37 degrees Celsius of CO2gas incubator Digestion, brighten when observing that attached cell is gradually rounded under the microscope and progressively disengage culture dish and float in cell pancreatin When, the second attached cell culture medium described in 1mL is added into culture dish, is mixed, to obtain cell suspension;
    (8) cell suspension is transferred to by carrying out the generation of Secondary Culture 2~20 in the coated culture device of gelatin, to obtain Obtain the donorcells of body-cell neucleus transplanting.
CN201310461790.9A 2013-09-29 2013-09-29 The method for cloning non-human animal is separated, cultivates the method for cell and carried out from blood Expired - Fee Related CN104513807B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310461790.9A CN104513807B (en) 2013-09-29 2013-09-29 The method for cloning non-human animal is separated, cultivates the method for cell and carried out from blood

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310461790.9A CN104513807B (en) 2013-09-29 2013-09-29 The method for cloning non-human animal is separated, cultivates the method for cell and carried out from blood

Publications (2)

Publication Number Publication Date
CN104513807A CN104513807A (en) 2015-04-15
CN104513807B true CN104513807B (en) 2018-01-12

Family

ID=52789679

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310461790.9A Expired - Fee Related CN104513807B (en) 2013-09-29 2013-09-29 The method for cloning non-human animal is separated, cultivates the method for cell and carried out from blood

Country Status (1)

Country Link
CN (1) CN104513807B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104739542A (en) * 2013-12-27 2015-07-01 深圳华大方舟生物技术有限公司 Method for improving transfer embryo use ratio of multiparous mammal
CN111088227A (en) * 2019-12-31 2020-05-01 广州航华生物医药科技有限公司 Cell separation culture solution and T cell separation culture method
CN111004780B (en) * 2019-12-31 2022-05-13 广州航华生物医药科技有限公司 Purification and separation culture method for improving killing activity of immune cells
JP7470276B2 (en) * 2020-09-23 2024-04-18 蘇州市立医院 Method for detecting neutrophil chemotaxis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001096532A2 (en) * 2000-06-15 2001-12-20 Tanja Dominko Method of generating pluripotent mammalian cells by fusion of a cytoplast fragment with a karyoplast
WO2006041910A2 (en) * 2004-10-05 2006-04-20 Trustees Of The University Of Pennsylvania Stem cells derived from uniparental embryos and methods of use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001096532A2 (en) * 2000-06-15 2001-12-20 Tanja Dominko Method of generating pluripotent mammalian cells by fusion of a cytoplast fragment with a karyoplast
WO2006041910A2 (en) * 2004-10-05 2006-04-20 Trustees Of The University Of Pennsylvania Stem cells derived from uniparental embryos and methods of use thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Mouse Cloning Using a Drop of Peripheral Blood;Satoshi Kamimura 等;《BIOLOGY OF REPRODUCTION》;20130626;第89卷(第2期);第1-6页 *
利用改进的手工克隆技术生产转GFP 基因猪克隆胚胎;张鹏 等;《遗传》;20110531;第33卷(第5期);第527-532页 *

Also Published As

Publication number Publication date
CN104513807A (en) 2015-04-15

Similar Documents

Publication Publication Date Title
CN104560870B (en) A kind of method for preparing decidua mescenchymal stem cell
US9617515B2 (en) Non-embryonic totipotent blastomere-like stem cells and methods therefor
CN108103011B (en) A kind of bovine oocyte in vitro maturation culture solution and cultural method
Maehara et al. Hollow fiber vitrification provides a novel method for cryopreserving in vitro maturation/fertilization-derived porcine embryos
CN104513807B (en) The method for cloning non-human animal is separated, cultivates the method for cell and carried out from blood
CN109689072A (en) Sperm activating agent and application thereof
CN102329771A (en) Method and special culture medium for subculturing chicken embryonic stem cells for long time
CN104004708A (en) Method for separation and purification, long-term passage cultivation, cryopreservation and recovery of sheep spermatogonia stem cells
CN105543164A (en) Primary isolated culture method for dairy cow mammary epithelial cells
CN108184818A (en) A kind of Human plactnta mesenchyma stem cell suspension protective agent
KR20100084620A (en) Cell composition for tissue regeneration
CN105200005A (en) Paralichthys olivaceus muscle satellite cell line establishing method, specific primer for identifying paralichthys olivaceus muscle satellite cell marker gene and application of specific primer
Hamra et al. Isolating highly pure rat spermatogonial stem cells in culture
CN107937444A (en) The method of somatic cell clone dog
CN1898380B (en) Method for separating cell from mammal gland secretion
CN107916249A (en) Improve the nutrient solution and cultural method of the development quality of bovine somatic cells clone's embryo and embryo in vitro fertilization
CN107858323B (en) Tortoise embryo fibroblast line and construction method thereof
Medvinsky et al. Analysis and manipulation of hematopoietic progenitor and stem cells from murine embryonic tissues
CN105838668A (en) In-vitro maturation culture solution for small follicle oocytes and application thereof
CN110669731A (en) Method for separating inherent and infiltrated macrophages of liver
CN101886059A (en) Culture solution used for embryo vitro production and method for bovine embryo vitro production
KR20080077738A (en) A methods to improve in vitro maturation of pig oocytes
EP0451217A1 (en) Production of horseshoe crab amebocytes in vitro
CN103509752B (en) Hubei white pig fetal fibroblast cell line
KR100767289B1 (en) Embryonic stem cell culture method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20200116

Address after: 518120 A205, Peng Fei Road, Dapeng street, Dapeng New District, Shenzhen, Guangdong, China, 7

Patentee after: Shenzhen Huada Gene Agriculture Holding Co.,Ltd.

Address before: 518083, 10 floor, Beishan Industrial Zone, 146 North Mountain Road, Yantian District, Guangdong, Shenzhen

Co-patentee before: BGI SHENZHEN Co.,Ltd.

Patentee before: BGI ARK BIOTECHNOLOGY Co.,Ltd. SHENZHEN

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20180112